Daimon S. et al., Goodpasture’s-like syndrome and effect of extracorporeal membrane oxygenator support. Intern Med 33: 569-73, 1994
Daimon S. et al., Antineutrophil cytoplasmic antibody-positive rapidly progressive glomerulonephritis caused by propylthiouracil. Clin Exper Nephrol 1: 225-228, 1997
Daimon S. and Koni I., Glomerular enlargement in the progression of mesangial proliferative glomerulonephritis. Clin Nephrol 49: 145-52, 1998
Daimon S. et al., Infective endocarditis-induced crescentic glomerulonephritis dramatically improved by plasmapheresis. Am J Kidney Dis 32: 309-13, 1998
Daimon S. et al., Efficacy of extracorporeal ultrafultration of ascetic fluid as a treatment of refractory ascites.Nephrol Dial Transplant 13: 2617-23, 1998
Daimon S. et al., Dextran sulphate cellulose columns for the treatment of nephritic syndrome due to inactive lupus nephritis.Nephrol Dial Transplant 15: 235-8, 2000
Daimon S. et al., LDL-apheresis followed by corticosteroid therapy as a possible treatment of cholesterol crystal embolism. Clin Exper Nephrol 4: 352-5, 2000
Daimon S. and Terai H.,Influence of Antiplatelet Medications on Bleeding Events in Hemodialysis Patients. Ther Apher Dial 15(5): 454-9, 2011
Daimon S. et al., Comparison of acetate-free citrate hemodialysis and bicarbonate hemodialysis regarding the effect of intra-dialysis hypotension and post-dialysis malaise. Ther Apher Dial 15(5): 460-5, 2011
Daimon S., Antiplatelet medication and the risk of bleeding in hemodialysis patients. In: Yuri F. Cabral, Marina Costa De Santos, ed. Hemodialysis: Indications, Procedures and Complications. Nova Publishers: 151-64, 2012
Daimon S. et al., Efficacy of coronary artery screening tests and intervention in hemodialysis patients. Ther Apher Dial 18(5): 443-9, 2014
Daimon S.,Comparison of the effect of the same dose of a 4-weekly continuous erythropoietin receptor activator administered once every 2 or 4 weeks in hemodialysis patients. Ther Apher Dial 18(5): 518-20, 2014
Daimon S. et al., Influence of continuous erythropoietin receptor activator (C.E.R.A.) administration intervals on erythropoietic effect in hemodialysis patients. Renal Replacement Therapy 2: 58, 2016
Daimon S. and Mizushima I., Effect of oral and intravenous iron therapy on hemoglobin levels in hemodialysis patients according to serum ferritin level. Renal Replacement Therapy 2: 63, 2016
Daimon S. Low dose oral iron as a safe and effective iron administration for anemia treatment in hemodialysis patients. Int J Hematol Ther 4(1): 25-30, 2018
Doi K., Nishitani M. et al., Influence of leakage from non-invasive positive pressure ventilation mask on FiO2 value delivered by home oxygen therapy concentrator: A bench study on stimulating patients with chronic obstructive pulmonary disease. Health 10: 919-27, 2018
Saito YC., Nishitani M. et al., Monoamines inhibit GABAergic neurons in ventroteral preoptic area that make direct synaptic connections to hypothalamic arousal neurons. J Neurosci 38(28): 6366-78, 2018
Doi K., Nishitani M. et al., Outline and issues of internet addiction. Biomed J Sci&Tech Res 6(5), 2018
Daimon S.,Adverse effect of antithrombotic medications on bleeding events and comparison of antithrombotic agents in hemodialysis patients. Ther Apher Dial 23(1): 32-7, 2019
Daimon S., Efficacy for anemia and changes in serum ferritin levels by long-term oral iron administration in hemodialysis patients.Ther Apher Dial 23(5): 444-50, 2019
Daimon S., Possible role of neocytolysis in anemia in hemodialysis patients with darbepoetin alfa or continuous erythropoietin receptor activator. Ther Apher Dial 24(5): 602-6, 2020
Daimon S.,Shortened red cell life span as a factor of anemia of mild inflammation in hemodialysis patients. Ther Apher Dial 24(6): 742-4, 2020
Daimon S., Yasuda M., Nishitani M., Serum carnitine concentration and the acyl to free carnitine ratio in nondialysis chronic kidney disease and hemodialysis patients. Ther Apher Dial 26(1): 122-9, 2022
Daimon S., Yasuda M., Maeda K., Effect of sacubitol-valsartan on cardiac function in hemodialysis patients. Ther Apher Dial 26(1): 244-5, 2022
Daimon S., Efficacy of daprodustat on anemia in hemodialysis patients with sustained inflammation: A case report. CEN Case Reports,2022 (in press)
Effect of antithrombotic medications on bleeding events and comparison of antithrombotic agents in hemodialysis patients.Daimon S et al,International Society of Nephrology (ISN) Frontiers Symposium 2018 (Tokyo Feb 22-25)
Antiplatelet medication and the risk of bleeding in hemodialysis patients. Shoichiro Daimon (2012 International Forum on Advances in Vaccines & Preventive Medicine, Whistler, Canada, Mar 16-17)